3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
108
Leukemia, Lymphocytic, Chronic, B-Cell
30
Myelodysplastic Syndromes
23
Leukemia, Biphenotypic, Acute
11
Recurrence
10
Lymphoma, Mantle-Cell
9
Leukemia
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myelomonocytic, Chronic
8
Burkitt Lymphoma
8
Waldenstrom Macroglobulinemia
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma
7
Hematologic Neoplasms
7
Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Myeloproliferative Disorders
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Follicular
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Multiple Myeloma
3
Anemia, Refractory, with Excess of Blasts
3
Sarcoma, Myeloid
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, B-Cell
2
Leukemia, Myeloid
2
Immunoglobulin Light-chain Amyloidosis
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Blast Crisis
2
Interventions
Bevacizumab
39
Paclitaxel
35
pembrolizumab
27
Carboplatin
27
Specimen Handling
21
olaparib
19
Magnetic Resonance Spectroscopy
19
Gemcitabine
19
liposomal doxorubicin
17
Cyclophosphamide
16
niraparib
13
fludarabine
12
Topotecan
12
Cisplatin
12
Biopsy
12
Taxes
9
Nivolumab
8
Immunoglobulin G
8
Fulvestrant
8
Doxorubicin
8
Disulfides
8
Surveys and Questionnaires
7
palbociclib
6
aldesleukin
6
Oxaliplatin
6
Letrozole
5
Fluorouracil
5
trastuzumab deruxtecan
4
oregovomab
4
mirvetuximab soravtansine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
venetoclax
×
90 days
×
Clear all
No trials found.